Evidence map›Paper›PMID 28729299›Full record

ArticleHaematologica2017

Notch2 blockade enhances hematopoietic stem cell mobilization and homing.

Weihuan Wang, Shuiliang Yu, Jay Myers, Yiwei Wang, William W Xin, Marwah Albakri, Alison W Xin, Ming Li, Alex Y Huang, Wei Xin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Haematologica, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Regulation of adult stem cell function by ketone bodies.Frontiers in cell and developmental biology · 2023
    Review
  10. Article
  11. Article
  12. Current Views on the Roles ofBiomolecules · 2021
    Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Weihuan WangDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Shuiliang YuDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Jay MyersDepartment of Pediatrics, Case Western Reserve University, Cleveland, OH, USA.
Yiwei WangDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
William W XinSchool of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA.
Marwah AlbakriDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Alison W XinHathaway Brown School, Shaker Heights, OH, USA.
Ming LiBiostatistics and Bioinformatics Core Facility, Case Comprehensive Cancer Center, School of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Alex Y HuangDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA lxz47@case.edu lan.zhou@case.edu.
Wei XinDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA.
Christian W SiebelDepartment of Molecular Biology Oncology, Genentech Inc., South San Francisco, CA, USA.
Hillard M LazarusDepartment of Medicine, Case Western Reserve University, Cleveland, OH, USA.
Lan ZhouDepartment of Pathology, Case Western Reserve University, Cleveland, OH, USA lxz47@case.edu lan.zhou@case.edu.
Case Western Reserve University · USUniversity of Pennsylvania · USShaker Heights Public Library · US

Funding

The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI AMITABH CHAK · 2015 to 2026
$15.6M
Targeting Notch2 in Hematopoietic Cell Therapy.R01HL103827 · NHLBI · METHODIST HOSPITAL RESEARCH INSTITUTE · PI ZHOU, LAN · 2012 to 2022
$4.3M
NHLBI NIH HHS R01 HL103827NIDDK NIH HHS P30 DK097948
6 · The paper itself

Abstract

Despite use of newer approaches, some patients being considered for autologous hematopoietic cell transplantation (HCT) may only mobilize limited numbers of hematopoietic progenitor cells (HPCs) into blood, precluding use of the procedure, or being placed at increased risk of complications due to slow hematopoietic reconstitution. Developing more efficacious HPC mobilization regimens and strategies may enhance the mobilization process and improve patient outcome. Although Notch signaling is not essential for homeostasis of adult hematopoietic stem cells (HSCs), Notch-ligand adhesive interaction maintains HSC quiescence and niche retention. Using Notch receptor blocking antibodies, we report that Notch2 blockade, but not Notch1 blockade, sensitizes hematopoietic stem cells and progenitors (HSPCs) to mobilization stimuli and leads to enhanced egress from marrow to the periphery. Notch2 blockade leads to transient myeloid progenitor expansion without affecting HSC homeostasis and self-renewal. We show that transient Notch2 blockade or Notch2-loss in mice lacking Notch2 receptor lead to decreased CXCR4 expression by HSC but increased cell cycling with CXCR4 transcription being directly regulated by the Notch transcriptional protein RBPJ. In addition, we found that Notch2-blocked or Notch2-deficient marrow HSPCs show an increased homing to the marrow, while mobilized Notch2-blocked, but not Notch2-deficient stem cells and progenitors, displayed a competitive repopulating advantage and enhanced hematopoietic reconstitution. These findings suggest that blocking Notch2 combined with the current clinical regimen may further enhance HPC mobilization and improve engraftment during HCT.

Indexed as

Hematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationAnimalsAntineoplastic AgentsBone Marrow CellsCell CycleCell DifferentiationCell MovementCell Self RenewalGene Expression RegulationHematopoietic Stem CellsHumansMiceMice, TransgenicReceptor, Notch2Receptors, CXCR4Antineoplastic AgentsNOTCH2 protein, humanReceptor, Notch2Receptors, CXCR4

Identifiers

PMID28729299
PMCPMC5622863
OpenAlexW2737148419

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.